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Abstract
Misregulation of post-translational modifications of microtubule-associated protein tau is
implicated in several neurodegenerative diseases including Alzheimer’s disease.
Hyperphosphorylation of tau promotes aggregation of tau monomers into filaments which are
common in tau-associated pathologies. Therefore, tau is a promising target for therapeutics and
diagnostics. Recently, high-affinity, high-specificity single-chain variable fragment (scFv)
antibodies against phosphorylated tau (pThr-231) were generated and the most promising variant
(scFv 3.24) displayed 20-fold increased binding affinity to pThr-231 tau compared to the wildtype scFv. The scFv 3.24 variant contained five point mutations, and intriguingly none were in
the tau binding site. The increased affinity was hypothesized to occur due to allosteric
communication between the framework (distal) region and the binding site. To examine the
mutational impact on the structure and dynamics of the scFv-pTau systems, multi-microsecond
all-atom molecular dynamics simulations were conducted for four systems – the wild-type
antibody and the 3.24 mutant, with and without tau. Correlation of All Rotameric and Dynamical
States (CARDS) software was used to quantify allostery in terms of mutual information (MI), or
the dependence between two variables. The mutant exhibited much higher total MI than the
wild-type as well as MI relative to target sites of interest, including the four residues that bind
directly to the phosphate group on tau. A recently developed machine learning method
(DiffNets), which is a supervised autoencoder with a classification task, was used to distinguish
the relevant motions separating wildtype from 3.24 mutant. Results showed long-range
expansion within the mutant stemming from mutation Ile61. Recent work has been aimed
towards quantifying optimal collective variables for discriminating wild-type from mutant
ensembles for use in free energy calculations.
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Introduction
Tau-Antibody binding
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and
amyotrophic lateral sclerosis are rising in prevalence due to increased life expectancy as well as
environmental factors (1). The potential culprit of the pathophysiology of these conditions is
post-translational modifications (PTMs). PTMs are changes to a synthesized amino acid chain
that form a mature protein and often have a role in protein regulation and, in certain cases, the
inception of disease. Hyperphosphorylation, or an abnormal or excessive addition of phosphate
groups to a protein, is one such PTM that is linked to the development of all the conditions listed
above (1-4). In particular, hyperphosphorylation of tau protein at serine, threonine, and tyrosine
residues is a hallmark of Alzheimer’s disease (AD) and is associated with the misfolding of tau
into neurofibrillary tangles (4). There is no cure for Alzheimer’s disease, and current diagnostic
methods leave much to be desired. While antibodies that bind to hyperphosphorylated tau protein
have been used commercially as a diagnostic technique and show potential for drug
development, their affinity and specificity to the desired region are too low. Creating antibodies
that bind to a specific PTM is difficult due to the dynamic nature of proteins and small regions of
modification compared to the rest of the molecule (5). In addition, current antibodies designed to
detect PTMs often bind to protein regions without the desired hyperphosphorylation, which can
lead to false diagnoses. Unfortunately, the specificity of many commercially available antibodies
has not been experimentally confirmed (5). While wet lab techniques such as random
mutagenesis followed by directed evolution have been used in the past to develop antibodies
with increased affinity and specificity for hyperphosphorylated tau protein, a computational
approach holds great promise in the field and will arguably play a major future role in drug
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development. Conducting simulations of molecular systems allows one to analyze protein
dynamics and gain a conceptual understanding of the biological actors on the stage of human
life. With a better knowledge of not only the amino acids in a protein but also how they
communicate with each other and other proteins to perform processes such as protein-ligand
binding, one can alter these structures to engineer a desired response or improve upon an existing
one.
Dr. Yongku Cho of UConn’s Chemical and Biomolecular Engineering department
generated an antibody with more than 20 times higher affinity to hyperphosphorylated tau and no
detectable increase in nonspecific binding (5). The antibody consists of 231 amino acids: 104
residues in the light chain and 127 in the heavy chain (6). There are three complementary
determining regions (CDRs), or hypervariable regions in an antibody that determine binding
specificity, in the light chain (CDR-L1, CDR-L2, and CDR-L3) and three CDRs in the heavy
chain (CDR-H1, CDR-H2, and CDR-H3). As revealed by the crystal structure determined by
Shih et al, epitope recognition occurs via eight hydrogen bonds, three salt bridges, and six
hydrophobic interactions (6). Contact with the phosphate group is dominated by CDR-H2, with
support of nearby amino acids accomplished by CDR-H3. CDR-H1, CDR-L1, CDR-L2, and
CDR-L3 assist in stabilization of the phosphoepitope (6). Refer to Figure 1 for a more detailed
description of the interactions between the CDRs and tau epitope.
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Figure 1: Antibody-phosphoepitope interactions. A) Schematic representation of the CDRs and
their interactions with the phosphate group on tau and nearby residues. B) and C) reveal the
interaction details between the tau epitope and antibody fragment. In B), CDR-H3 is represented
using an electrostatic surface model, with negatively charged areas in red and positively
charged areas in blue. In C), CDR-H3 is colored magenta and represented as sticks, with
magenta being carbon, blue being nitrogen, and red being oxygen. The CDRs in the light chain
are displayed in yellow and side chains are represented as sticks, with yellow being carbon and
red being oxygen. The tau epitope is represented as gray sticks, with gray being carbon, nitrogen
being blue, and oxygen being red. Hydrogen bonds are displayed with dashed lines, and the
disulfide bond within CDR-H3 is labeled SS bond. Figure taken from (6).
The antibody includes three mutations in the light chain (threonine to alanine at position
41, asparagine to glycine at position 52, and threonine to isoleucine at position 61) and two
mutations in the heavy chain (glycine to cysteine at position 75 and alanine to valine at position
97). The mutation locations are depicted in Figure 2. Interestingly, the mutations which led to the
most effective antibodies were not in the regions that directly bind to tau protein (5).
6

Figure 2: Structure of antibody mutant (mutant 3.24) that is investigated in this study. Here
the light chain is in purple, the heavy chain is in green, the tau epitope is in red, and the
mutations are highlighted in cyan. Image rendered in PyMOL.
Without an easily delineated biomolecular mechanism evident that differentiates the
binding of the mutant from the binding of the wildtype to hyperphosphorylated tau protein, it is
difficult to predict functionality from structure or propose new antibody structures with improved
binding affinity/specificity. We have hypothesized that the improved affinity of these antibodies
can be explained in terms of allostery, or long-distance communication between the amino acids
in the antibody. This was tested through molecular dynamics simulations of the tau-antibody
system for both the wildtype and mutant in order to differentiate the two binding mechanisms
and discover potential avenues for diagnostics and treatment.

Computational Approach
The future of medicine will rely heavily on the use of computer-generated biophysical
models to interpret and predict molecular processes. An experimental approach allows one to see
how life behaves in a natural environment, however, due to the complexity of those systems and
environments, experimental methods may lack insight into the underlying mechanisms behind
how molecules interact and why these interactions occur. A computational approach allows one
7

to put a magnifying glass to the biophysical principles dictating how molecules move and derive
theories for how this dictates actions at a larger scale. In the seminal Feynman Lectures on
Physics (1963), Nobel prize winning theoretical physicist Richard Feynman stated that
“everything that living things do can be understood in terms of the jiggling and wiggling of
atoms” (7). This jiggling of atoms is largely random but ultimately built on concrete probabilities
of motion that result from the molecule’s energy landscape, which is determined by the
molecule’s structure. If the energies that act upon a system can be quantified, one can also
determine the forces that are exerted on the system as force is the negative of the derivative of
the potential energy function.
At the heart of biomolecular simulation, one can utilize Newton’s second law of motion:
force equals mass times acceleration. In this manner forces that act upon a system can be used to
find the acceleration of the system, allowing one to build a trajectory of motion for the
molecule(s) in question. The potential energy function U is composed of the mathematical
representation of all the factors that influence a molecule’s motion, such as bonds, bond angles,
torsions, Van der Waals forces, and electrostatic interactions. This equation comprises the force
field of a molecular dynamics simulation. Using this force field, one can input a structure file of
a molecular system, generate initial velocities, and determine a possible trajectory of motion that
the molecule(s) can assume. This trajectory can then be used to analyze the dynamics of the
system in question.
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Analytical Techniques
Molecular dynamics simulation data was analyzed to compute root-mean-square
deviation (RMSD) and root-mean-square fluctuation (RMSF) quantities, determination of mutual
information to quantify allostery, and the generation of machine learning networks.
RMSD Analysis
The root-mean-square deviation of atomic coordinates is one of the most popular
analytical tools for determining the differences between macromolecular structures. It is
frequently used to ascertain the quality of molecular dynamics simulations and the equilibration
period of a given trajectory (10). To compute the RMSD, first a least-squares fit is done to
minimize the difference between two superimposed structures; in the case of determining
equilibration of a simulation, these two structures are the initial and subsequent frames of the
trajectory. After the two structures are superimposed, the RMSD (in length units) is calculated
according to the equation

1
Where δi is the distance between atom i in reference structure and atom i current structure, and
N is the total number of equivalent atoms used in the calculation (11). RMSD calculations
require identical numbers of atoms in both structures, and for this reason as well as to reduce
noise in the results, it is normally computed using only the backbone heavy atoms of each amino
acid. RMSD analysis has limitations; for example, it cannot reveal local flexible regions, in other
words, it cannot distinguish between a molecule in which some regions are very rigid and some
very flexible and a molecule in which all regions are semi-flexible (10). However, RMSD can be
used to determine a holistic degree of difference between two structures, allowing one to
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iteratively view how a given molecule in a simulation changes from an initial reference point
over time.
RMSF Analysis
Root-mean-square fluctuation of atomic positions allows one to determine flexibility of a
residue over the course of a simulation. It measures the fluctuation of individual residues relative
to a reference position, which is typically the time-averaged position of the amino acid. RMSF
analysis can thus help one determine regions of the molecule that are more flexible and regions
that are more rigid, whereas RMSD provides a more global metric. RMSF is calculated
according to the equation

2
Where T is frames, vt is is the coordinate of an atom at time t, and 𝑣̅ is the ensemble averaged
position of the same atom (11).
Mutual Information Analysis
In probability theory, mutual information (MI) refers to the mutual dependence between
two random variables. In abstract terms, it quantifies the degree of information obtained about
one random variable from another random variable. MI can thus be used to determine how much
the movement of one dihedral reveals about the movement of another dihedral, revealing
whether these motions are correlated. In this manner, one can measure the correlated motions, or
allosteric communication, within a protein. The MI between dihedrals can be summed to find the
total MI of the system for a holistic sense of allostery, or MI of the dihedrals in the protein can
be measured relative to a target site of interest, for example, amino acids that are crucial for
binding.
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CARDS software characterizes mutual information I according to the equation

3
Where x ∈ X represents the amount of states dihedral X can adopt, y ∈ Y represents the
amount of states dihedral Y can adopt, p(x) is the probability that dihedral X adopts state x, p(y)
is the probability that dihedral Y adopts state y, and p(x,y) is the joint probability that both X
adopts state x and Y adopts state y (8). For more information on ordered versus disordered
regimes, normalization of MI, and holistic calculations of MI, refer to the supplementary
equations. For target site analysis, CARDS takes the average mutual information between two
dihedral sets: dihedrals in the reference residue and nearest neighbor (within 3 Angstroms) and
all dihedrals in the target site (8).
Machine Learning Analysis
In order to interpret the many degrees of freedom present in a conformational ensemble
for a molecular system, several dimensionality reduction algorithms exist that condense these
motions into a smaller set of understandable variables. However, one typical limitation of these
techniques is that preference is given to distinguishing between large motions instead of smaller
ones that may be more relevant to binding dynamics and other properties. For example, principal
component analysis (PCA) determines linear combinations of features in order to keep the
maximum amount of geometric variance in the original data set, which ultimately assumes that
larger structural changes are more relevant than smaller ones (9). There are many molecular
systems for which this assumption is faulty, for example, there are many enzymes that have a
large loop that undergoes arbitrary motions, which will be interpreted as important by PCA,
while subtle motions in the active site are more biochemically relevant. Machine learning
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provides an opportunity to overcome this problem. Unlike PCA, which considers linear
combinations of features, autoencoders consider nonlinear combinations of features (9). An
autoencoder consists of an encoder, which reduces the dimensionality of the input into a latent
space, and a decoder, which expands this latent space to construct the original input, in this case,
a three-dimensional reconstruction of a protein’s configuration (9). The latent space is optimized
in order to accurately reconstruct this input. Unfortunately, autoencoders still emphasize the
collection of large geometric variations. The literature suggests the use of supervised
autoencoders to accurately identify features that differentiate between structures. Supervision
adds the requirement that the condensed variables be able to predict a label, for example,
whether the structural input came from the wildtype or a given mutant (9). This forces the
machine learning network to focus on what degrees of freedom are important for distinguishing
between two states rather than automatically putting emphasis on large geometric motions. The
classification task in the latent space can be applied to the whole molecule or limited to a
specified region, such as an active site, in order to study a particular area. For a schematic
representation, see Figure 3.
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Figure 3: Schematic representation of a standard autoencoder on the left and a sample
DiffNet on the right. The encoder reduces the input into the latent space and the decoder
expands it to reconstruct the input. The custom DiffNet shown in the figure contains two
encoders: a supervised encoder that acts upon the atoms near a given mutation (shown in cyan)
and an unsupervised encoder that operates on the other atoms in the protein (shown in blue).
The latent layers constructed by the two encoders are concatenated and trained in order produce
the reconstructed input.
Input for DiffNets includes a trajectory from one structure and a trajectory from another
molecular system, which are then broken down into frames that are used by the software to train
a supervised autoencoder to accurately identify the variables that separate the two structures. One
challenge faced by this approach is that there is likely to be overlap between the two
conformational ensembles, i.e, there are structural states that the two systems may have in
common. It is thus unrealistic to classify all states present in one variant as different from the
states present in the other variant. In order to avoid this, DiffNets uses an expectation
maximization scheme, which iteratively changes training labels to determine a set of structural
states that are probabilistically more likely to occur in one variant versus another while allowing
the conformational ensembles of the two variants to overlap (9). For some of the mathematics
behind DiffNets theory, refer to the supplementary equations.
The Bowman lab at the University of Washington at St. Louis successfully used DiffNets
to determine small structural differences that predicted the duty ratios of myosin isoforms and
relative stabilities of β-lactamase variants (9). It is hypothesized that DiffNets should be able to
identify the relevant structural properties that inform the biochemical variations between other
molecular systems. In this study, DiffNets was used to identify the structural signatures that
predict enhanced binding in the 3.24 mutant as opposed to the wildtype.
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Research Aims
In the analyses of the biomolecular simulation, allosteric communication was quantified
in terms of mutual information, a term in probability theory that refers to the dependence
between two variables. Mutual information was measured using Correlation of All Rotameric
and Dynamical States, or CARDS, software, produced by the Bowman lab at the University of
Washington at St. Louis (8). CARDS can be utilized to find the total mutual information of a
system and the mutual information in the system relative to a target site of one’s choosing.
Mutual information identifies the differences between the wildtype and mutant but fails to show
whether these are biochemically important and what the functional differences between the
wildtype and mutant are. Machine learning can be used to build a network that finds the relevant
differences that can accurately classify wildtype versus mutant ensembles. The software DiffNets
was used from the Bowman lab at University of Washington at St. Louis, which uses a
supervised autoencoder that also contains a classification task (9).
The objectives of this study are as follows:
1. Generate molecular dynamics simulations of the wildtype and mutant 3.24 antibodies
with and without hyperphosphorylated tau protein.
2. Use the biomolecular simulations of the wildtype and mutant 3.24 antibodies with and
without hyperphosphorylated tau protein to determine the total mutual information of the
antibodies and analyze the differences between mutual information of the wildtype and
mutant.
3. Determine the mutual information of the wildtype and mutant antibodies relative to key
binding sites in the antibody structure.
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4. Utilize machine learning methods to identify relevant motions that separate the wildtype
and mutant antibodies in terms of biochemical function.
The overarching goal of this study was to try to learn design rules that could inform future
antibody design decisions.

Methods
System Preparation
All of the simulations in this study were performed in a Unix-based operating system
with access to UConn’s High Performance Computing (HPC) cluster utilized for running and
processing trajectories. Access to a computer for connecting to the cluster and for simulation
analysis was provided through the May lab.
In order to run a molecular dynamics simulation, one needs force field parameters, a
structure file that provides the initial Cartesian coordinates of the system, and a method of
solvating, relaxing, and equilibrating the molecule(s). For the simulations in this study,
CHARMM-GUI (12-13) was used for system setup and solvation. For information on the
contents of each simulation (wildtype vs. mutant with and without tau) and simulation length,
refer to Table 1. The structure files for simulations are most often taken from the Protein
DataBase (pdb) where scientists upload molecular structures that they have determined for open
access. For this study, the wildtype antibody structure was taken from file 4GLR, and the mutant
was generated by inserting point mutations at the appropriate residues using CHARMM-GUI
software. There were 3260 atoms in the wildtype structure, 3266 in the mutant, and 175 in the
tau epitope.
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For all systems, the CHARMM-36m (14) force field and TIP3P (15) water model were
used. Each solvation box was fit to the system with 10 Angstrom buffers on all sides. NaCl was
added to reach a concentration of 150 mM, resulting in an average total system size of
approximately 36,000 atoms. GROMACS (16-17) software was used to perform energy
minimization over 10,000 steps. For NVT equilibration (keeping volume and temperature
constant), temperature was held at 310.15 K for 25,000 steps with rvdw_switch of 1.0 nm, rvdw
of 1.2 nm, and dt of 0.001 ps. The Nose-Hoover thermostat was used with full electrostatic
interactions calculated via the PME method.
Production Runs
For the production runs, NPT equilibration was performed (keeping the pressure and
temperature constant) using the Parrinello-Rahman barostat with isotropic scaling at 1 atm and
Nose-Hoover thermostat, the same water model and force field as above, PME, and a Verlet
cutoff scheme with short-range nonbonded interactions calculated with a cutoff of 12 Angstroms.
A timestep of 2 fs was used with frames saved every 10 ps. For details regarding individual
simulations, refer to Table 1. After the generation of the trajectories, each system was processed
to correct for periodic boundary conditions.

Table 1: Simulation systems and legnths. All systems were run for 2 trials of 2 μs each. The
trials were concatenated to build 4 μs trajectories for each system.
Simulation Number

Contents

Length

1

Wildtype antibody and tau

2 μs

2

Wildtype antibody and tau

2 μs

3

Wildtype antibody only

2 μs

4

Wildtype antibody only

2 μs

5

Mutant antibody and tau

2 μs
16

6

Mutant antibody and tau

2 μs

7

Mutant antibody only

2 μs

8

Mutant antibody only

2 μs

Methodology and System Validation
In order to determine the stability of the systems, RMSD (backbone after least squares fit
to backbone) and RMSF analyses were performed using concatenated trajectories. Referring to
Table 1, trials 1 and 2 were combined to produce 4 μs of simulation for the wildtype and tau
system, trials 3 and 4 were combined to produce 4 μs of simulation for the wildtype only system,
trials 5 and 6 were combined to produce 4 μs of simulation for the mutant and tau system, and
trials 7 and 8 were combined to produce 4 μs of simulation for the mutant only system.
Mutual Information
Holistic mutual information was calculated for each system’s 4 μs concatenated
trajectories using CARDS software. The first 100 ns of the individual trials were removed in
order to give the system time to equilibrate. In order to test the convergence of MI, the 4 μs
trajectory of the wildtype bound to tau was used to create smaller trajectories with lengths of 500
ns, 900 ns, 1500 ns, 1900 ns, and 3800 ns, respectively. The total holistic MI of each trajectory
was determined and plotted to determine the minimum trajectory length needed to measure MI,
which was determined to be 1900 ns (see Supplementary Figure 1).
MI was calculated for each 4 μs trajectory relative to key target sites. A 1900 ns
trajectory for each system was used to measure the MI relative to each CDR in the antibody.
Preliminary results identified three target sites for which relative mutual information was
significantly different in the mutant than the wildtype: CDR-H2, the portion of CDR-H2 that
directly surrounds the phosphate group, and CDR-L3 (see Supplementary Table 1). MI was then
17

determined for each 4 μs trajectory (with the first 100 ns removed from each trial) relative to
these sites.
In order to test whether all the five mutations present were needed for enhanced mutual
information, five new antibodies were generated using CHARMM-GUI software in which one
point mutation was removed in each with the other 4 mutations seen in the original mutant
present. For each system, a different point mutation was removed (see Table 2). 2 μs of
simulation was run for each system with the same setup as the previous experiments. The first
100 ns was removed from each trajectory, total MI was calculated, and MI relative to the chosen
target sites was determined.

Table 2: Construction of new mutants with one mutation in the 3.24 mutant removed per
system. In each structure, a different mutation was removed.
System Number

Mutation Missing

1

THR to ALA, AA 41, light chain

2

ASP to GLY, AA 52, light chain

3

THR to ILE, AA 61, light chain

4

GLY to CYS, AA 75, heavy chain

5

ALA to VAL, AA 97, heavy chain

DiffNets
For the systems that included tau, the trajectories were processed so that only the
antibody was included. Two DiffNets were generated with one being trained with the wildtype
and mutant trajectories from the tau-bound systems and the other with the wildtype and mutant
trajectories from the unbound systems. A third DiffNet was constructed with the mutant
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trajectory from the tau-bound system as one set of input and the mutant simulation from the
unbound system as the other. 4 μs trajectories were used as input for all systems.

Results and Discussion
System Validation
RMSD analysis of the backbone of each system fit to the backbone reveal that the
structures in each trajectory were overall stable, with all system trajectories having a maximum
RMSD of no more than 0.3 nm, or 3 Angstroms (see Figure 4). To observe more local
fluctuations, RMSF analysis was performed for each system (wildtype bound, wildtype unbound,
3.24 mutant bound, and 3.24 mutant unbound), revealing a maximum RMSF of no more than
0.55 nm, or 5.5 Angstroms, for each residue in each system (see Figure 5). RMSD and RMSF
results reveal that the antibodies in each system were stable and thus likely a reliable
representation of the molecules in question.
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Figure 4: RMSD of the wildtype and mutant antibodies in Tau-bound and unbound
simulations. The backbone of each structure was fit to the initial structure. All structures were
determined to be overall stable with a maximum RMSD of no more than 0.3 nm, or 3 Angstroms
(maximum RMSD seen in the unbound mutant).
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Figure 5: RMSF of residues in the wildtype and mutant antibody in Tau-bound and unbound
simulations. A maximum RMSF of no more than 0.55 nm was observed (maximum RMSF seen in
the bound mutant).
Mutual Information and Target Site Analysis
For the wildtype and the mutant bound and unbound, the holistic mutual information was
summed to find the total MI of each system. The data reveals elevated MI in the mutant as
opposed to the wildtype when comparing both the bound and unbound states (see Figure 6A).
For each system, the total MI relative to CDR-H2, the portion of CDR-H2 that forms a cage
around the phosphate group on tau, and CDR-L3 were summed. One can see elevated MI in the
3.24 mutant compared to the wildtype in the bound states for all target sites and enhanced MI in
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the mutant relative to the portion of CDR-H2 that binds to the phosphate group on tau and CDRL3 in the unbound states (see Figure 6B and 6C).

Figure 6: Mutual information of the wildtype and 3.24 mutant bound and unbound. A) total
mutual information of the wildtype and mutant bound and unbound. In the mutant, MI is elevated
in both the bound and unbound states. B) MI of the wildtype and mutant in the unbound states
relative to CDR-H2 (CDR2), the CDR-H2 binding pocket (CDR2 binding pocket), and CDR-L3
(CDR3). One can see a significant degree of elevated MI in the mutant compared to the wildtype
relative to the CDR-H2 binding pocket and CDR-L3. C) MI of the wildtype and mutant in the
bound states relative to CDR-H2 (CDR2), the CDR-H2 binding pocket (CDR2 binding pocket),
and CDR-L3 (CDR3). One can see a significant degree of elevated MI in the mutant compared to
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the wildtype relative to all target sites. Values determined via a bootstrapping procedure in
which each trajectory was broken up into 50 ns increments and put back together at random for
20 new trajectories. The average MI of each trajectory was reported with error bars reflecting
standard deviation between the rebuilt trajectories.
The MI was also investigated for each individual residue in mutant 3.24 (bound state).
With the exception of mutation THR to ILE, all the point mutations corresponded to regions of
elevated MI relative to the portion of CDR-H2 that binds to the phosphate group on tau (see
Figure 7), potentially revealing a network of allosteric communication.

Figure 7: Mutual information of residues in the bound mutant relative to the portion of CDRH2 that binds to the phosphate group. Four of the five mutations (Ala41, Gly52, Cys179, and
Val201) exhibit elevated MI compared to the other residues in the protein.
The same analyses were performed on the five new mutants (where one mutation was
removed) generated from the 3.24 mutant structure. The total MI of the mutants in the unbound
state were all less than that of the 3.24 mutant, demonstrating that all mutations were necessary
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for enhanced total MI (see Figure 8A). The MI relative to the identified target sites was also
calculated for the five new systems in the unbound state (Figure 8B) and the bound state (Figure
8C). One can see that with the exception of system 1, all of the new mutants displayed less MI
than the 3.24 mutant relative to the target sites that paralleled the MI levels of the wildtype.
Since the total MI of system 1 in the unbound state was significantly less than that of mutant
3.24 and comparable with that of the wildtype, the data revealed that overall, all mutations were
necessary for enhanced MI.
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Figure 8: Mutual information of the wildtype, 3.24 mutant and new mutants. A) total MI of
antibody structures in the unbound state. B) MI of antibody structures in the unbound state
relative to target sites CDR2 (CDR-H2), the CDR2 binding pocket (CDR-H2 binding pocket),
and CDR3 (CDR-L3). C) MI of antibody structures in the bound state relative to the
aforementioned target sites.
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DiffNets Analysis
Construction of DiffNets revealed key expansions in the 3.24 mutant compared to the wildtype,
allowing one to visualize potential allosteric communication that is enhanced in the mutant.
When the DiffNets architecture determined relevant motions distinguishing mutant from
wildtype, it revealed expansions emanating from Ile61 (one of the mutations) in both the bound
and the unbound states (see Figure 9). In the bound state, expansion also occurred near another
mutation (Ala201). These motions may aid in the identification of a binding mechanism that
links the distant framework region to the binding site, which could inform antibody design.

Figure 9: Relevant motions distinguishing 3.24 mutant from wildtype. The DiffNets detected
expansion in the mutant relative to the wildtype emanating from Ile61 in the bound (left) and
unbound (right) states. The blue lines signify expansion, and the red lines signify compression.
Another DiffNet was constructed in which the 3.24 mutant in the bound state was used as one set
of input and the mutant in the unbound state was used as the other. A morphed structure of the
mutant from the unbound to bound state revealed high variation in the region closest to the tau
epitope, indicating that the configuration of these binding loops is different in the unbound state
to the bound state (see Figure 10). If one plays a trajectory of ten frames moving from most
unbound character to most bound character, one can see the loops closing in like a clamp,
26

potentially revealing one portion of the binding mechanism that, if discovered in its entirety and
linked to the expansion seen in the rest of the protein, could inform intentional drug design.

Binding site à
Figure 10: Morphed structure of the mutant from the unbound to the bound state. Ten
structures were aligned that were classified as various degrees of “1”, or bound, character as
opposed to “0”, or unbound, character. Regions of high variation can be seen in the bottom
loops, which appear to form a binding clamp.
Future Directions
Results from this study identify enhanced allosteric communication in the 3.24 mutant
that may explain higher binding affinity to hyperphosphorylated tau protein and reveal potential
expansions that could comprise a step in the network linking the framework region with the point
mutations to the binding site. Future steps would be to further characterize these allosteric
communication networks in order to identify collective variables that could be used in free
energy calculations. Steered molecular dynamics simulations, or simulations that exert a force on
a region of interest rather than simply equilibrating the system, can reveal the binding energetics
between two areas and could be used to identify a residue that can be changed in order to
increase the binding affinity of the system. Once a new mutant is designed, steered MD can be
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used to investigate its binding affinity to hyperphosphorylated tau. In order to test the specificity
of the antibody, steered MD can be used to determine the binding affinity to normal tau, which
should remain low in order to be a good candidate.

Conclusions
It can be concluded that the 3.24 mutant contains increased total allosteric
communication compared to the wildtype for both the bound and unbound states as determined
by mutual information calculations. It can also be concluded that allosteric communication was
increased in the mutant relative to key binding sites compared to the wildtype for both the bound
and unbound states. All five of the point mutations seen in the 3.24 mutant were determined to
be necessary for increased allosteric communication. Finally, it can be concluded that increased
allosteric communication can be seen as long-range expansions in the mutant compared to the
wildtype in both the bound and unbound states. This expansion was shown to be emanating from
mutation Ile61.
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Supplementary Material
Mutual Information: see (8) for reference
CARDS software calculated dihedral angles with MDTraj, assigned them to rotameric states
gauche+, gauche-, and trans for most χ angles and cis or trans for backbone dihedrals. TransitionBased Assignment (TBA) was used to delineate lasting transitions from transient motions.
CARDS determines if a length of time between two transitions is more ordered or disordered
using a liklihood ratio L(t) in which a value of L(t) greater than 3 to characterize disorder and
any value of L(t) less than 3 is considered ordered.
See Introduction to Analytical Techniques for the calculation of mutual information I(X,Y).
Mutual information is normalized through the equation
4
Where C(x,y) is the channel capacity, or maximum MI between two dihedrals. It accounts for the
fact that different dihedrals have a different number of available states.
The holistic correlations between two dihedrals are characterized by the equation
5
Where (moving from left to right) the first term is the normalized MI between two rotameric
(ordered) states, the second term is the normalized MI between dihedral X’s romateric state and
dihedral Y’s dynamical (disordered) state, the third is the normalized MI between the dynamical
state of X and rotameric state of Y, and the fourth term is the normalized MI between the
dynamical state of X and that of Y. For calculating the MI relative to a target site, CARDS takes
the average MI between two dihedral sets: dihedrals in the reference residue and nearest
neighbor (within 3 Angstroms) and all dihedrals that are present in the target site.
Diffnets: see (9) for reference
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For data pre-processing, the trajectories and structure files are stripped down to the backbone
coordinates without carbonyl oxygens. The trajectories are centered and then aligned to the
crystal structure. The coordinates are mean-shifted to 0 via the equation

6
Where xmean-free is the mean-shifted trajectory, xi is a single frame,

is the mean of the XYZ

coordinates, and Nt is the number of frames in the trajectory.
Data was whitened using the equation

7
Where 𝑥% is the whitened trajectory and C00 is the covariance matrix for the XYZ coordinates.
For the training step, three loss functions were used to minimize reconstruction error,
classification error, and correlation of latent space variables, respectively.
8
Reconstruction error loss (which discourages outliers and directs reconstructions to the proper
XYZ coordinates) is expressed by the equation

9
Where Nn is the number of output nodes, Nb is the number of examples in a training batch, xij is a
target XYZ coordinate, and. 𝑥&
!" is the output value.
The classification term, which penalizes errors made by the latent space, is expressed as
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Where Nb is the number of examples in a training batch, yi is the target value, and 𝑦(! is the output
of the classification layer.
The last term, which minimizes the covariance between the latent space variables, is expressed
via the equation

Where Cov(Zi, Zf) is the covariance matrix of Z (the latent vector) across all samples in the
training batch.

Supplementary Figure 1: Convergence of total MI for bound wildtype. One can see that the
total MI converges at approximately 1900 ns.
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Supplementary Table 1: Mutual information of the wildtype and 3.24 mutant bound and
unbound for key target sites. The data reveals that the greatest differences in MI for the bound
states are relative to CDR-H2 and CDR-L3, which informed future target site analysis. MI was
calculated over 1900 ns trajectories for each system.
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